Suppr超能文献

AMPK-caspase-6 轴控制非酒精性脂肪性肝炎中的肝损伤。

An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis.

机构信息

Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.

Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.

出版信息

Science. 2020 Feb 7;367(6478):652-660. doi: 10.1126/science.aay0542.

Abstract

Liver cell death has an essential role in nonalcoholic steatohepatitis (NASH). The activity of the energy sensor adenosine monophosphate (AMP)-activated protein kinase (AMPK) is repressed in NASH. Liver-specific AMPK knockout aggravated liver damage in mouse NASH models. AMPK phosphorylated proapoptotic caspase-6 protein to inhibit its activation, keeping hepatocyte apoptosis in check. Suppression of AMPK activity relieved this inhibition, rendering caspase-6 activated in human and mouse NASH. AMPK activation or caspase-6 inhibition, even after the onset of NASH, improved liver damage and fibrosis. Once phosphorylation was decreased, caspase-6 was activated by caspase-3 or -7. Active caspase-6 cleaved Bid to induce cytochrome c release, generating a feedforward loop that leads to hepatocyte death. Thus, the AMPK-caspase-6 axis regulates liver damage in NASH, implicating AMPK and caspase-6 as therapeutic targets.

摘要

肝细胞死亡在非酒精性脂肪性肝炎(NASH)中起着重要作用。能量传感器腺苷单磷酸(AMP)激活的蛋白激酶(AMPK)的活性在 NASH 中受到抑制。肝特异性 AMPK 敲除加重了 NASH 小鼠模型的肝损伤。AMPK 磷酸化促凋亡半胱氨酸蛋白酶-6 蛋白以抑制其激活,从而抑制肝细胞凋亡。抑制 AMPK 活性可解除这种抑制,使 caspase-6 在人和 NASH 小鼠中激活。即使在 NASH 发生后,AMPK 激活或 caspase-6 抑制也可改善肝损伤和纤维化。一旦磷酸化减少,caspase-6 就会被 caspase-3 或 caspase-7 激活。活性 caspase-6 切割 Bid 以诱导细胞色素 c 释放,形成一个正反馈环,导致肝细胞死亡。因此,AMPK-caspase-6 轴调节 NASH 中的肝损伤,提示 AMPK 和 caspase-6 是治疗靶点。

相似文献

1
An AMPK-caspase-6 axis controls liver damage in nonalcoholic steatohepatitis.
Science. 2020 Feb 7;367(6478):652-660. doi: 10.1126/science.aay0542.
2
From overnutrition to liver injury: AMP-activated protein kinase in nonalcoholic fatty liver diseases.
J Biol Chem. 2020 Aug 21;295(34):12279-12289. doi: 10.1074/jbc.REV120.011356. Epub 2020 Jul 10.
3
FTZ attenuates liver steatosis and fibrosis in the minipigs with type 2 diabetes by regulating the AMPK signaling pathway.
Biomed Pharmacother. 2021 Jun;138:111532. doi: 10.1016/j.biopha.2021.111532. Epub 2021 Apr 3.
5
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models.
EBioMedicine. 2018 May;31:122-132. doi: 10.1016/j.ebiom.2018.04.009. Epub 2018 Apr 8.
7
Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis.
Cell Mol Gastroenterol Hepatol. 2021;12(2):653-664. doi: 10.1016/j.jcmgh.2021.04.009. Epub 2021 Apr 21.
10
Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Am J Physiol Gastrointest Liver Physiol. 2021 Apr 1;320(4):G450-G463. doi: 10.1152/ajpgi.00158.2020. Epub 2021 Jan 13.

引用本文的文献

1
Discovery and mechanistic insights of dibenzoylmethane as a broad spectrum inhibitor of coronavirus.
PLoS Pathog. 2025 Sep 8;21(9):e1013492. doi: 10.1371/journal.ppat.1013492. eCollection 2025 Sep.
2
Liver-specific loss of perturbs lipid metabolism and hepatocyte integrity.
Autophagy Rep. 2025 Sep 2;4(1):2551028. doi: 10.1080/27694127.2025.2551028. eCollection 2025.
3
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
4
Isoform-specific roles of AMP-activated protein kinase in cardiac physiology and pathophysiology.
Front Cardiovasc Med. 2025 Aug 8;12:1638515. doi: 10.3389/fcvm.2025.1638515. eCollection 2025.
5
Pemafibrate Ameliorates Steatotic Liver Disease Regardless of Endothelial Dysfunction in Mice.
Antioxidants (Basel). 2025 Jul 20;14(7):891. doi: 10.3390/antiox14070891.
6
Liver, ageing and disease.
Nat Rev Gastroenterol Hepatol. 2025 Jul 28. doi: 10.1038/s41575-025-01099-z.
7
Rhizoma Atractylodis Macrocephalae reduces HFD-induced MAFLD in mice through activated AMPK-mediated inhibition of fatty acid synthesis.
Liver Res. 2025 Apr 15;9(2):157-168. doi: 10.1016/j.livres.2025.04.004. eCollection 2025 Jun.
9
Hepatic glycogen directly regulates gluconeogenesis through an AMPK/CRTC2 axis in mice.
J Clin Invest. 2025 Jun 2;135(11). doi: 10.1172/JCI188363.

本文引用的文献

1
ER Stress Drives Lipogenesis and Steatohepatitis via Caspase-2 Activation of S1P.
Cell. 2018 Sep 20;175(1):133-145.e15. doi: 10.1016/j.cell.2018.08.020. Epub 2018 Sep 13.
2
Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer.
Nature. 2018 Jul;559(7715):637-641. doi: 10.1038/s41586-018-0350-5. Epub 2018 Jul 18.
3
Mechanisms of NAFLD development and therapeutic strategies.
Nat Med. 2018 Jul;24(7):908-922. doi: 10.1038/s41591-018-0104-9. Epub 2018 Jul 2.
4
TBK1 at the Crossroads of Inflammation and Energy Homeostasis in Adipose Tissue.
Cell. 2018 Feb 8;172(4):731-743.e12. doi: 10.1016/j.cell.2018.01.007.
5
AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development.
EBioMedicine. 2018 Feb;28:194-209. doi: 10.1016/j.ebiom.2018.01.008. Epub 2018 Jan 9.
6
Fighting the fatty liver.
Nature. 2017 Oct 11;550(7675):S102-S103. doi: 10.1038/550S102a.
7
Activation of Skeletal Muscle AMPK Promotes Glucose Disposal and Glucose Lowering in Non-human Primates and Mice.
Cell Metab. 2017 May 2;25(5):1147-1159.e10. doi: 10.1016/j.cmet.2017.04.010.
8
Activation and regulation of caspase-6 and its role in neurodegenerative diseases.
Annu Rev Pharmacol Toxicol. 2015;55:553-72. doi: 10.1146/annurev-pharmtox-010814-124414. Epub 2014 Oct 17.
10
Cell death and cell death responses in liver disease: mechanisms and clinical relevance.
Gastroenterology. 2014 Oct;147(4):765-783.e4. doi: 10.1053/j.gastro.2014.07.018. Epub 2014 Jul 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验